This inventor holds 1 USPTO granted patent. Top assignee: Je Il Pharmaceutical Co., Ltd.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Young-Chul Kim: Innovator in Pharmaceutical Chemistry
Introduction
Young-Chul Kim is a prominent inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic potential.
Latest Patents
Young-Chul Kim holds a patent for a tricyclic derivative or pharmaceutically acceptable salts thereof, along with its preparation method and pharmaceutical composition. This invention relates to a novel tricyclic derivative that exhibits efficient inhibitory activity against poly(ADP-ribose) polymerases (PARP). The tricyclic derivative is particularly useful for the prevention or treatment of diseases caused by excess PARP activity, including neuropathic pain, neurodegenerative diseases, cardiovascular diseases, diabetic nephropathy, inflammatory diseases, osteoporosis, and cancer.
Career Highlights
Young-Chul Kim is associated with Je Il Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work focuses on creating innovative solutions to address various health challenges through pharmaceutical advancements.
Collaborations
Some of his notable coworkers include Myung-Hwa Kim and Seung-Hyun Kim, who contribute to the collaborative efforts in their research endeavors.
Conclusion
Young-Chul Kim's innovative work in pharmaceutical chemistry highlights his commitment to developing effective treatments for complex diseases. His contributions are paving the way for advancements in medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile